<DOC>
	<DOCNO>NCT01415531</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety , tolerability 8 week therapy nebivolol comparison placebo young patient 18 - 54 year age stage 1 stage 2 essential hypertension .</brief_summary>
	<brief_title>Study Efficacy Safety Nebivolol Younger Patients ( 18 - 54 Years )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Male female outpatient , age 18 54 year Patients diagnose stage 1 stage 2 essential hypertension Normal physical examination finding electrocardiogram ( ECG ) result abnormal finding judge Investigator clinically significant Secondary hypertension severe hypertension History Type 1 diabetes mellitus A medical contraindication discontinue current antihypertensive therapy Clinically significant respiratory disease prohibit use beta blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Stage 1</keyword>
	<keyword>Stage 2</keyword>
	<keyword>Hypertension</keyword>
</DOC>